Junghae Suh

Dr. Junghae Suh joined Biogen in 2019 as head of the Gene Therapy Accelerator Unit (GTxAU) to develop transformative gene therapies for the treatment of neurological diseases. Dr. Suh received her S.B. in Chemical Engineering from MIT in 1999 and a Ph.D. in Biomedical Engineering from Johns Hopkins School of Medicine in 2004. She then completed a two-year postdoctoral fellowship in the Laboratory of Genetics at the Salk Institute for Biological Studies. Prior to Biogen, she was a tenured member of the faculty in the department of Bioengineering at Rice University. She was awarded the NSF CAREER Award and the Outstanding New Investigator Award from the American Society for Gene and Cell Therapy for her innovative work on reprogramming viruses as therapeutic platforms. Her academic work was funded by the National Institutes of Health, National Science Foundation, and the American Heart Association. Most recently, she was inducted into the American Institute for Medical and Biological Engineering College of Fellows.